Antiphospholipid Antibodies and Stroke Management – RPTH
RPTH Journal shared a post on LinkedIn about a recent article by Macy L.E. Gatti et al, published in International Society on Thrombosis and Haemostasis adding:
“Cryptogenic stroke and weakly positive antiphospholipid antibodies: what is the right antithrombotic strategy?
Antiphospholipid antibodies (aPLs) are found in a subset of patients with cryptogenic stroke.
For strongly positive aPLs, warfarin is often favoured, but what should we do when the antibodies are only weakly positive?
Evidence is scarce. A new retrospective cohort study in RPTH Journal from the University of Pennsylvania Health System sheds some light.
Key findings from 47 patients with cryptogenic stroke or TIA and persistent aPLs (30 weakly positive, 17 strongly positive):
- Clinicians recommended warfarin less often (P equals .007) and antiplatelet agents more often (P equals .03) in patients with weakly positive aPLs
- Recurrent ischaemic stroke incidence: 0.169 events/person-year in the strongly positive group vs 0.045 in the weakly positive group (HR 3.93; 95% CI 1.14–13.55; P = .03)
- 3-year stroke-free survival: 93% in weakly positive vs 58% in strongly positive patients
- Bleeding events were rare in both groups
This signal is useful: patients with weakly positive aPLs had a lower incidence of recurrent stroke despite less intensive antithrombotic therapy, while those with strongly positive aPLs remained at high risk. Prospective studies are needed to define the best treatment for each group.
Title: Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies
Authors: Macy L. E. Gatti, Steven R. Mess, Adam Cuker

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis
-
Nov 18, 2026, 20:55Nasir Jamal: Plasmapheresis – Key Concepts at a Glance
-
Nov 18, 2026, 20:55Tarık Seller: Pulmonary Embolism – When a Blood Clot Becomes a Life-Threatening Emergency
-
Nov 18, 2026, 20:53Sandya Arunachalam: Bringing the Profession Together at the Haemostasis and Thrombosis Workshop
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons